AN OPEN STUDY INVOLVED 14 ITALIAN CENTERS AND 348 HOSPITALIZED PATIENTS OF BOTH SEXES, AGED 61.57 +- 12.54 (MEAN VALUE) WITH COPD IN ACUTE PHASE. ALL PATIENTS WERE TREATED WITH YHE CARBOCYSTEINE AND SOBREROL COMBINATION FOR 10 CONSECUTIVE DAYS. RESULTS SHOWED THAT THE QUANTITY AND VISCOSITY OF THE SPUTUM AND THE CORRELATING CLINICAL SYMPTOMS AND THE RESPIRATORY PARAMETERS WERE FAVOURABLY INFLUENCED BY THE DRUG. SAFETY WAS EXCELLENT.
RICERCA POLICENTRICA SU UNA LARGA CASISTICA DI PAZIENTI OSPEDALIZZATI,AFFETTI DA BPCO IN FASE DI RIACUTIZZAZIONE,TRATTATI CON L'ASSOCIAZIONE CARBOCISTEINA-SOBREROLO
RIPARI, Patrizio;DI GIOACCHINO, Mario;
1988-01-01
Abstract
AN OPEN STUDY INVOLVED 14 ITALIAN CENTERS AND 348 HOSPITALIZED PATIENTS OF BOTH SEXES, AGED 61.57 +- 12.54 (MEAN VALUE) WITH COPD IN ACUTE PHASE. ALL PATIENTS WERE TREATED WITH YHE CARBOCYSTEINE AND SOBREROL COMBINATION FOR 10 CONSECUTIVE DAYS. RESULTS SHOWED THAT THE QUANTITY AND VISCOSITY OF THE SPUTUM AND THE CORRELATING CLINICAL SYMPTOMS AND THE RESPIRATORY PARAMETERS WERE FAVOURABLY INFLUENCED BY THE DRUG. SAFETY WAS EXCELLENT.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.